A Long-Term Study of Aripiprazole in Patients With Major Depressive Disorder
Public ClinicalTrials.gov record NCT00095745. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Long-Term, Open-label, Study to Assess the Safety and Tolerability of Aripiprazole as an Adjunctive Therapy in the Treatment of Outpatients With Major Depressive Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This trial is a 52-week safety study to evaluate the safety of adjunctive aripiprazole in outpatients with major depressive disorder who have experienced an incomplete response to an ongoing antidepressant trial.
Study identification
- NCT ID
- NCT00095745
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,002 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2004
- Primary completion
- Oct 31, 2007
- Completion
- Oct 31, 2007
- Last update posted
- Nov 7, 2013
2004 – 2007
United States locations
- U.S. sites
- 58
- U.S. states
- 30
- U.S. cities
- 58
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution | Mesa | Arizona | — | — |
| Local Institution | Peoria | Arizona | — | — |
| Local Institution | Beverly Hills | California | — | — |
| Local Institution | Burbank | California | — | — |
| Local Institution | Encino | California | — | — |
| Local Institution | Garden Grove | California | — | — |
| Local Institution | National City | California | — | — |
| Local Institution | Orange | California | — | — |
| Local Institution | Pasadena | California | — | — |
| Local Institution | Riverside | California | — | — |
| Local Institution | San Diego | California | — | — |
| Local Institution | Denver | Colorado | — | — |
| Local Institution | Farmington | Connecticut | — | — |
| Local Institution | Washington D.C. | District of Columbia | — | — |
| Local Institution | Gainesville | Florida | — | — |
| Local Institution | Jacksonville | Florida | — | — |
| Local Institution | Orlando | Florida | — | — |
| Local Institution | Atlanta | Georgia | — | — |
| Local Institution | Smyrna | Georgia | — | — |
| Local Institution | Chicago | Illinois | — | — |
| Local Institution | Edwardsville | Illinois | — | — |
| Local Institution | Oakbrook Terrace | Illinois | — | — |
| Local Institution | Terre Haute | Indiana | — | — |
| Local Institution | Overland Park | Kansas | — | — |
| Local Institution | Wichita | Kansas | — | — |
| Local Institution | Lexington | Kentucky | — | — |
| Local Institution | Rockville | Maryland | — | — |
| Local Institution | Springfield | Massachusetts | — | — |
| Local Institution | Farmington Hills | Michigan | — | — |
| Local Institution | Okemos | Michigan | — | — |
| Local Institution | Albuquerque | New Mexico | — | — |
| Local Institution | Brooklyn | New York | — | — |
| Local Institution | New York | New York | — | — |
| Local Institution | Staten Island | New York | — | — |
| Local Institution | Chapel Hill | North Carolina | — | — |
| Local Institution | Raleigh | North Carolina | — | — |
| Local Institution | Cincinnati | Ohio | — | — |
| Local Institution | Toledo | Ohio | — | — |
| Local Institution | Portland | Oregon | — | — |
| Local Institution | Philadelphia | Pennsylvania | — | — |
| Local Institution | Pittsburgh | Pennsylvania | — | — |
| Local Institution | East Providence | Rhode Island | — | — |
| Local Institution | Charleston | South Carolina | — | — |
| Local Institution | Memphis | Tennessee | — | — |
| Local Institution | Austin | Texas | — | — |
| Local Institution | Dallas | Texas | — | — |
| Local Institution | Houston | Texas | — | — |
| Local Institution | Salt Lake City | Utah | — | — |
| Local Institution | Woodstock | Vermont | — | — |
| Local Institution | Arlington | Virginia | — | — |
| Local Institution | Charlottesville | Virginia | — | — |
| Local Institution | Herndon | Virginia | — | — |
| Local Institution | Richmond | Virginia | — | — |
| Local Institution | Bellevue | Washington | — | — |
| Local Institution | Seattle | Washington | — | — |
| Local Institution | Morgantown | West Virginia | — | — |
| Local Institution | Brown Deer | Wisconsin | — | — |
| Local Institution | Middleton | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00095745, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 7, 2013 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00095745 live on ClinicalTrials.gov.